75 related articles for article (PubMed ID: 12033187)
1. Assessing nuke toxicity.
TreatmentUpdate; 2002 Mar; 14(3):3-4. PubMed ID: 12033187
[No Abstract] [Full Text] [Related]
2. Depletion of mitochondrial DNA in HIV-1-infected patients and its amelioration by antiretroviral therapy.
Miura T; Goto M; Hosoya N; Odawara T; Kitamura Y; Nakamura T; Iwamoto A
J Med Virol; 2003 Aug; 70(4):497-505. PubMed ID: 12794710
[TBL] [Abstract][Full Text] [Related]
3. Protection from nuke side effects.
TreatmentUpdate; 2002 Dec; 14(9):3-4. PubMed ID: 12593383
[No Abstract] [Full Text] [Related]
4. Depletion of mitochondrial DNA copies/cell in peripheral blood mononuclear cells in HIV-1-infected treatment-naïve patients.
Maagaard A; Holberg-Petersen M; Kvittingen EA; Sandvik L; Bruun JN
HIV Med; 2006 Jan; 7(1):53-8. PubMed ID: 16313293
[TBL] [Abstract][Full Text] [Related]
5. Symptomatic hyperlactatemia in an HIV-positive patient: a case report and discussion.
Antoniou T; Weisdorf T; Gough K
CMAJ; 2003 Jan; 168(2):195-8. PubMed ID: 12538549
[TBL] [Abstract][Full Text] [Related]
6. The case against Zerit.
Huff B
GMHC Treat Issues; 2002 Oct; 16(10):1-4. PubMed ID: 12458548
[No Abstract] [Full Text] [Related]
7. NRTI-related mitochondrial toxicity in an HIV-infected woman.
Jenny-Avital ER
AIDS Clin Care; 2003 Oct; 15(10):87-9. PubMed ID: 14666921
[No Abstract] [Full Text] [Related]
8. Mitochondrial DNA and nucleoside toxicity.
Casademont J; Miró O; Cardellach F
N Engl J Med; 2002 Jul; 347(3):216-8; author reply 216-8. PubMed ID: 12125711
[No Abstract] [Full Text] [Related]
9. Lactic acid and nuke damage.
TreatmentUpdate; 2002 Nov; 14(8):5-6. PubMed ID: 12501824
[No Abstract] [Full Text] [Related]
10. Check-ups for the power plant?
TreatmentUpdate; 2002 Mar; 14(3):2. PubMed ID: 12033186
[No Abstract] [Full Text] [Related]
11. Hyperlactatemia and lactic acidosis: should routine screening be considered?
Moyle G
AIDS Read; 2002 Aug; 12(8):344-8. PubMed ID: 12229891
[No Abstract] [Full Text] [Related]
12. Of power plants and energy shortages.
TreatmentUpdate; 2001 May; 13(1):3-4. PubMed ID: 11570256
[No Abstract] [Full Text] [Related]
13. Face to face with lipoatrophy. An interview with David Nolan by Nelson Vergel.
Nolan D
GMHC Treat Issues; 2005; 19(3-4):1-6. PubMed ID: 16003843
[No Abstract] [Full Text] [Related]
14. Risk factors for lactic acidosis in HIV-infected patients treated with nucleoside reverse-transcriptase inhibitors: a case-control study.
Bonnet F; Bonarek M; Morlat P; Mercié P; Dupon M; Gemain MC; Malvy D; Bernard N; Pellegrin JL; Beylot J
Clin Infect Dis; 2003 May; 36(10):1324-8. PubMed ID: 12746780
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial DNA and nucleoside toxicity.
Rastegar DA
N Engl J Med; 2002 Jul; 347(3):216-8; author reply 216-8. PubMed ID: 12125710
[No Abstract] [Full Text] [Related]
16. To nuke, or not to nuke?
Proj Inf Perspect; 2007 Apr; (43):1-3. PubMed ID: 17684823
[No Abstract] [Full Text] [Related]
17. Nucleoside-related mitochondrial toxicity among HIV-infected patients receiving antiretroviral therapy: insights from the evaluation of venous lactic acid and peripheral blood mitochondrial DNA.
Montaner JS; Côté HC; Harris M; Hogg RS; Yip B; Harrigan PR; O'Shaughnessy MV
Clin Infect Dis; 2004 Mar; 38 Suppl 2():S73-9. PubMed ID: 14986278
[TBL] [Abstract][Full Text] [Related]
18. A test for mitochondrial toxicity.
Nagy GS
AIDS Clin Care; 2002 May; 14(5):47-8. PubMed ID: 12004881
[No Abstract] [Full Text] [Related]
19. Complications & side effects. Nukes and fat wasting.
TreatmentUpdate; 2004; 16(7):3-4. PubMed ID: 17225282
[No Abstract] [Full Text] [Related]
20. Effect of the substitution of one nucleoside analogue by one non-nucleoside reverse transcriptase inhibitor over mitochondrial DNA levels.
De Felipe B; Blanco A; Soriano-Sarabia N; Muñoz-Fernández MA; Genebat M; Vallejo A; Leal M
Infection; 2008 Jun; 36(3):266-70. PubMed ID: 18463785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
